Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir in Kaposi Sarcoma
NCT03077451Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Mar 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of nelfinavir in Kaposi sarcoma (KS), sponsored by AIDS Malignancy Consortium. Started Mar 2017; status: completed.
02
Drugs
nelfinavir
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT03077451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077451.